Sentences with phrase «monoclonal antibody therapy»

«The acquisition demonstrates our determination to lead the animal health industry in the development and commercialization of monoclonal antibody therapies in areas of high medical need,» said Alejandro Bernal, DVM, MS, MBA, an executive vice president and group president a Zoetis.

There is also an injectable medication (such as Cytopoint) that uses new monoclonal antibody therapy to target and block specific molecules that activate itching.

Since 2010, clinical trials have tried to target and neutralize that HERV - W - coded protein using monoclonal antibody therapy (MAT).

Given the scalability of DNA manufacturing and ease of DNA delivery relative to conventional recombinant protein monoclonal antibody therapies, the DMAb platform has potential to greatly expand the market for monoclonal antibody prophylaxis / therapy against challenging infectious disease targets.

Ofatumumab and rituximab are monoclonal antibody therapy medications that target the protein CD20, which is found on immune system B cells.

Several experimental Ebola vaccines and monoclonal antibody therapies currently are in development.

The committee then applied these criteria to all existing NIH - funded studies and concluded that only current — as opposed to future — development of monoclonal antibody therapies passed the test.

Tribodies ™ are T - cell engaging tri-specific recombinant antibodies, which recruit cytotoxic T lymphocytes and have the potential to be much more effective than conventional monoclonal antibody therapies.

«Additionally, the new monoclonal antibody therapy has allowed me to give rapid comfort to some itchy atopic dogs, and it is thrilling to have this technology in veterinary medicine at last.

Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory, from a single type of immune system cell.

He worked in various disciplines including vaccinology, immunology, stem cell biology, cellular signaling mechanisms, and monoclonal antibody therapy of tumors.

Monoclonal antibody therapy is the fastest growing therapeutic area in human medicine.

Zoetis was recognized with top honors in the categories of Best New Product — Companion Animal for the monoclonal antibody therapy CYTOPOINT ™ and Best New Product Portfolio for a portfolio of new canine products launched in 2016, including CYTOPOINT ™, Simparica ® (sarolaner) and VANGUARD ® vaccines.